Erzofri Extended-Release Drug Interactions: 186 Major
Erzofri Extended-Release (Paliperidone Palmitate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Erzofri Extended-Release. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Paliperidone can be increased when combined with Abatacept.
Level 1 evidence
Abiraterone
The metabolism of Paliperidone can be decreased when combined with Abiraterone.
Level 1 evidence
Abrocitinib
The serum concentration of Paliperidone can be increased when it is combined with Abrocitinib.
Level 2 evidence
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Paliperidone.
Level 2 evidence
Acebutolol
Acebutolol may increase the orthostatic hypotensive activities of Paliperidone.
Level 2 evidence
Acetazolamide
The risk or severity of CNS depression can be increased when Acetazolamide is combined with Paliperidone.
Level 2 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Paliperidone.
Level 2 evidence
Adagrasib
The serum concentration of Paliperidone can be increased when it is combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Paliperidone can be increased when combined with Adalimumab.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Paliperidone.
Level 2 evidence
Albuterol
The therapeutic efficacy of Salbutamol can be decreased when used in combination with Paliperidone.
Level 2 evidence
Alfentanil
The risk or severity of CNS depression can be increased when Alfentanil is combined with Paliperidone.
Level 2 evidence
Enter your NPI to unlock 20 major interactions for Erzofri Extended-Release
Erzofri Extended-Release (Paliperidone Palmitate) has 1284 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Erzofri Extended-Release (Paliperidone Palmitate) has 186 major, 577 moderate, and 521 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Erzofri Extended-Release. Always confirm against the full prescribing information.